Friday, October 6th, 2006
Nano-Drug’s Dirty Little Secret ETC Group’s September 2006 report on nanomedicine, Nanotech Rx, requires some updating. After all, it’s nearly 30 days old. Our report mentions the nano-drug Abraxane, and it acknowledges that approval of the cancer drug was a watershed event for the nanotech industry. But important details are emerging. On October 1 the [...]
Tuesday, September 5th, 2006
The Economist this week has a Special Report on Synthetic Biology , the new field of building artificial life forms from scratch. As is to be expected from the Economist, this is a fairly upbeat assesment of the technology that fails to mention the growing opposition to Synthetic Biology, signalled a few months ago when almost forty civil society groups, trade unions and scientific associations signed an open letter calling for caution.
Here at ETC we have been busy writing our own special report on Synthetic Biology (which we are calling ‘Extreme Genetic Engineering’ –
Tuesday, January 31st, 2006
Not content with heading for the stars, the corporate sponsored X-Foundation that awards the X-prize has now set a bounty for commericalising the neXt frontier – the human genome. According to this article in the Wall Street Journal the X-foundation will award a new X-prize of between $5-$20 million to the first inventor of a gene sequencer that can decode the DNA of 100 people in a matter of weeks. behind it is craig venter, the genomics mogul.
Keep up to date with our website by subscribing to email updates:
If you know what you’re doing with RSS feeds then subscribe to the feed.
(et cet er a) and other things; such as human rights, biodiversity, biopiracy, converging technologies, global governance and corporate concentration. An experimental growing plot for news, views and new ideas.
